Exosome Therapy Revolution: Clinical Innovation, Market Expansion, and the Road Ahead
Extracellular vesicles have moved from lab curiosity to a genuine drug-development category. The exosomes market now spans oncology, neurology, dermatology, and regenerative medicine, with the current forecast window running 2025 through 2034 across the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan — even though not a single exosome-based therapy has secured full approval...
0 Commentarii 0 Distribuiri 279 Views 0 previzualizare